How AI Can Streamline Market Access and Reimbursement – From Dossier Writing to Strategic Decision-Making

10 September 2025, 13:00 - 13:45 PM CET (*)

Free Educational Webinar
With AI and market access expert Dr Stefan Walzer

Payers and HTA agencies expect ever-increasing levels of evidence, speed, and strategic clarity when evaluating new health technologies. Meanwhile, internal teams are often stretched thin, facing mounting data complexity and global reimbursement variation.

AI offers a transformative opportunity to close these gaps: from accelerating evidence generation and automating dossier creation to simulating pricing negotiations and optimising launch strategies.
 

Join our upcoming educational webinar and learn from AI and market access expert Dr Stefan Walzer:

  • Where and how AI can be integrated in the market access process

  • How AI-based tools can reduce time and resource demands in dossier writing

  • What HTA bodies and payers really accept when it comes to AI-supported evidence

  • Live demonstration of use cases in pricing, objection handling, and launch planning

Dr Stefan Walzer

Register now and discover how AI can help your team work smarter, not harder, in market access:

REGISTER NOW ➤

 

Please note that this webinar is only open to managers working in pharma/biotech/medtech companies. For your registration to be approved, please enter your COMPANY EMAIL address.

(*) If you cannot attend the webinar, please note that a recorded playback will be sent to all registrants after the webinar.

 

About Dr Stefan Walzer:

  • As the founder and CEO of MArS Market Access & Pricing Strategy GmbH, Dr Stefan Walzer initiated the application of AI platforms and tools in the area of market access to revolutionise dossier preparation, payer negotiations, and strategic decision-making.

  • Stefan's impressive career includes pivotal roles such as Global Payer Strategy Leader at F. Hoffmann – La Roche AG, author of over 40 peer-reviewed articles and 400 abstracts, as well as serving as a recognised lecturer on market access, pricing, and negotiation at leading universities in Germany.

  • Stefan holds a PhD in Health Economics from the University of Zurich, alongside qualifications from the University of Tübingen and the London School of Hygiene & Tropical Medicine.

Learn more from Stefan at the following 2-day course:

The AI for Pharma Market Access Course
With Dr Stefan Walzer
Dr. Stefan Walzer